Whitney Graybill to Clinical Trials as Topic
This is a "connection" page, showing publications Whitney Graybill has written about Clinical Trials as Topic.
Connection Strength
0.192
-
Poly(ADP-ribose) polymerase (PARP) inhibitors as treatment versus maintenance in ovarian carcinoma. Gynecol Oncol. 2017 07; 146(1):11-15.
Score: 0.106
-
Vintafolide: a novel targeted agent for epithelial ovarian cancer. Future Oncol. 2014 Mar; 10(4):541-8.
Score: 0.086